Letters and urgent communications 2024 | Department of Health

Advice from the Chief Medical Officer to HSC professionals for 2024

Documents

HSS(MD) 01/2024 - National Patient Safety Alert – Shortage Of Glp-1 Receptor Agonists (Update)
PDF (190 KB)

HSS(MD) 02/2024 - Seasonal Influenza Vaccination offer to all 50-64 year olds and all Health and Social Care Workers
PDF (127 KB)

HSS (MD) 03/2024 - MHRA Drug Safety Update – Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell
PDF (204 KB)

HSS (MD) 04/2024 - Fluoroquinolone antibiotics and Omega-3-acid ethyl ester medicines
PDF (176 KB)

HSS (MD) 05/2024 - Measles, Mumps and Rubella catch-up campaign February to March 2024
PDF (188 KB)

HSS(MD) 06 2024 - Valporate - Important new regulatory measure for oversight of prescribing to new patients and existing female patients
PDF (371 KB)

HSS(MD) 07 2024 - MHRA Drug safety update – codeine linctus (codeine oral solutions) reclassification to prescription-only medicine
PDF (198 KB)

HSS(MD) 08 2024 - MHRA Drug safety update – Pseudoephedrine very rare risk of Posterior reversible encephalopathy syndrome (PRES) and Reversible cerebral vasoconstriction syndrome (RCVS)
PDF (171 KB)

HSS(MD) 09 2024 - National Patient Safety Alert – Shortage of Salbutamol 2.5MG 2.5ML AND 5MG 2.5ML Nebuliser Liquid Unit Dose Vials
PDF (173 KB)

HSS(MD) 10 2024 - Update to covid-19 testing guidance HSS(MD) circulars withdrawn
PDF (126 KB)

HSS (MD) 11 2024 - Covid-19 2024 Spring Booster Programme
PDF (229 KB)

HSS (MD) 12 2024 Covid-19 Treatments Updated Nice Guidance TA878 (Nirmatrelvir plus ritonavir sotrovimab and tocilizumab for treating COVID-19)
PDF (145 KB)

Help viewing documents